U.S. Computational Biology Market Size, Share & Trends Analysis Report By Service (Database, Infrastructure & Hardware, Software Platform), By Application (Preclinical Drug Development, Clinical Trial), By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                        1.2.1. Service Segment
                        1.2.2. Application Segment
                        1.2.3. End-use Segment
                    1.3. Research Assumptions
                    1.4. Information Procurement
                        1.4.1. Primary Research
                    1.5. Information or Data Analysis
                    1.6. Market Formulation & Validation
                    1.7. Market Model
                    1.8. U.S. Market: CAGR Calculation
                    1.9. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Trends and Outlook
                    3.3. Market Dynamics
                        3.3.1. Growing Adoption Of Bioinformatics Technology
                        3.3.2. Advancements In Genomic Research
                        3.3.3. Increasing Demand For Personalized Medicines
                    3.4. Market Restraint Analysis
                        3.4.1. Lack of Skilled Professional
                        3.4.2. Data Privacy And Security Concerns
                    3.5. Business Environment Analysis
                        3.5.1. PESTEL Analysis
                        3.5.2. Porter’s Five Forces Analysis
                        3.5.3. COVID-19 Impact Analysis
Chapter 4. Service Business Analysis
                    4.1. Computational Biology Market: Service Movement Analysis
                    4.2. Databases
                        4.2.1. Databases Market, 2018 - 2030 (USD Million)
                    4.3. Infrastructure & Hardware
                        4.3.1. Infrastructure & Hardware, 2018 - 2030 (USD Million)
                    4.4. Software Platform
                        4.4.1. Software Platform Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
                    5.1. Computational Biology Market: Application Movement Analysis
                    5.2. Drug Discovery & Disease Modelling
                        5.2.1. Drug Discovery & Disease Modelling Market, 2018 - 2030 (USD Million)
                        5.2.2. Target Identification
                            5.2.2.1. Target Identification Market, 2018 - 2030 (USD Million)
                        5.2.3. Target Validation
                            5.2.3.1. Target Validation Market, 2018 - 2030 (USD Million)
                        5.2.4. Lead Discovery
                            5.2.4.1. Lead Discovery Market, 2018 - 2030 (USD Million)
                        5.2.5. Lead Optimization
                            5.2.5.1. Lead Optimization Market, 2018 - 2030 (USD Million)
                    5.3. Preclinical Drug Development
                        5.3.1. Preclinical Drug Development Market, 2018 - 2030 (USD Million)
                        5.3.2. Pharmacokinetics
                            5.3.2.1. Pharmacokinetics Market, 2018 - 2030 (USD Million)
                        5.3.3. Pharmacodynamics
                            5.3.3.1. Pharmacodynamics Market, 2018 - 2030 (USD Million)
                    5.4. Clinical Trials
                        5.4.1. Clinical Trials Market, 2018 - 2030 (USD Million)
                        5.4.2. Phase I
                            5.4.2.1. Phase I Market, 2018 - 2030 (USD Million)
                        5.4.3. Phase II
                            5.4.3.1. Phase II Market, 2018 - 2030 (USD Million)
                        5.4.4. Phase III
                            5.4.4.1. Phase III Market, 2018 - 2030 (USD Million)
                        5.4.5. Phase IV
                            5.4.5.1. Phase IV Market, 2018 - 2030 (USD Million)
                    5.5. Computational Genomics
                        5.5.1. Computational Genomics Market, 2018 - 2030 (USD Million)
                    5.6. Computational Proteomics
                        5.6.1. Computational Proteomics Market, 2018 - 2030 (USD Million)
                    5.7. Others
                        5.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. End-use Business Analysis
                    6.1. Computational Biology Market: End-use Movement Analysis
                    6.2. Academic & Research
                        6.2.1. Academic & Research Market, 2018 - 2030 (USD Million)
                    6.3. Industrial
                        6.3.1. Industrial Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Company Categorization
                    7.2. Strategy Mapping
                    7.3. Company Market Share/Position Analysis, 2023
                    7.4. Company Profiles/Listing
                        7.4.1. DNAnexus, Inc.
                            7.4.1.1. Company Overview
                            7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.4.1.3. Product Benchmarking
                            7.4.1.4. Strategic Initiatives
                        7.4.2. Illumina, Inc.
                            7.4.2.1. Company Overview
                            7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.4.2.3. Product Benchmarking
                            7.4.2.4. Strategic Initiatives
                        7.4.3. Thermo Fisher Scientific, Inc.
                            7.4.3.1. Company Overview
                            7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.4.3.3. Product Benchmarking
                            7.4.3.4. Strategic Initiatives
                        7.4.4. Schrödinger, Inc.
                            7.4.4.1. Company Overview
                            7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.4.4.3. Product Benchmarking
                            7.4.4.4. Strategic Initiatives
                        7.4.5. Compugen
                            7.4.5.1. Company Overview
                            7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.4.5.3. Product Benchmarking
                            7.4.5.4. Strategic Initiatives
                        7.4.6. Aganitha AI Inc.
                            7.4.6.1. Company Overview
                            7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.4.6.3. Product Benchmarking
                            7.4.6.4. Strategic Initiatives
                        7.4.7. Genedata AG
                            7.4.7.1. Company Overview
                            7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.4.7.3. Product Benchmarking
                            7.4.7.4. Strategic Initiatives
                        7.4.8. QIAGEN
                            7.4.8.1. Company Overview
                            7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.4.8.3. Product Benchmarking
                            7.4.8.4. Strategic Initiatives
                        7.4.9. SIMULATIONS PLUS
                            7.4.9.1. Company Overview
                            7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.4.9.3. Product Benchmarking
                            7.4.9.4. Strategic Initiatives
                        7.4.10. Fios Genomics
                            7.4.10.1. Company Overview
                            7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.4.10.3. Product Benchmarking
                            7.4.10.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. computational biology market, by service, 2018 - 2030 (USD Million)
Table 4 U.S computational biology market, by application, 2018 - 2030 (USD Million)
Table 5 U.S computational biology market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 U.S. computational biology market- Key market driver analysis
Fig. 7 U.S. computational biology market - Key market restraint analysis
Fig. 8 U.S. computational biology market - Porter’s Five Forces analysis
Fig. 9 U.S. computational biology market - PESTEL analysis
Fig. 10 U.S. computational biology market: Service outlook key takeaways
Fig. 11 U.S. computational biology market: Service movement analysis
Fig. 12 Databases market estimates, 2018 - 2030 (USD Million)
Fig. 13 Infrastructure & hardware market estimates, 2018 - 2030 (USD Million)
Fig. 14 Software platform market estimates, 2018 - 2030 (USD Million)
Fig. 15 U.S. computational biology market: Application outlook key takeaways
Fig. 16 U.S. computational biology market: Application movement analysis
Fig. 17 Drug discovery & disease modelling market estimates, 2018 - 2030 (USD Million)
Fig. 18 Target identification market estimates, 2018 - 2030 (USD Million)
Fig. 19 Target validation market estimates, 2018 - 2030 (USD Million)
Fig. 20 Lead discovery market estimates, 2018 - 2030 (USD Million)
Fig. 21 Lead optimization market estimates, 2018 - 2030 (USD Million)
Fig. 22 Preclinical drug development market estimates, 2018 - 2030 (USD Million)
Fig. 23 Pharmacokinetics market estimates, 2018 - 2030 (USD Million)
Fig. 24 Pharmacodynamics market estimates, 2018 - 2030 (USD Million)
Fig. 25 Clinical trials market estimates, 2018 - 2030 (USD Million)
Fig. 26 Phase I market estimates, 2018 - 2030 (USD Million)
Fig. 27 Phase II market estimates, 2018 - 2030 (USD Million)
Fig. 28 Phase III market estimates, 2018 - 2030 (USD Million)
Fig. 29 Phase IV market estimates, 2018 - 2030 (USD Million)
Fig. 30 Computational genomics market estimates, 2018 - 2030 (USD Million)
Fig. 31 Computational proteomics market estimates, 2018 - 2030 (USD Million)
Fig. 32 Others market estimates, 2018 - 2030 (USD Million)
Fig. 33 U.S. computational biology market: End-use outlook key takeaways
Fig. 34 U.S. computational biology market: End-use movement analysis
Fig. 35 Academic & research market estimates, 2018 - 2030 (USD Million)
Fig. 36 Industrial market estimates, 2018 - 2030 (USD Million)
Fig. 37 Strategy framework